Code: ONDYDB1
Yourgene DPYD Test for pharmacogenetic screening of 5-FU drug metabolism. CE IVD certified for toxicity risk assessment.
Loading...
The Yourgene DPYD test provides pharmacogenetic screening for dihydropyrimidine dehydrogenase (DPYD) gene variants that affect 5-fluorouracil (5-FU) drug metabolism. This test helps identify patients at risk of severe toxicity from fluoropyrimidine-based chemotherapy.
Key Features
- Detects clinically relevant DPYD gene variants
- Predicts 5-FU drug metabolism and toxicity risk
- CE IVD certified for diagnostic use
- PCR-based genotyping methodology
- Supports personalized chemotherapy dosing
Clinical Applications
- Pre-treatment screening for 5-FU chemotherapy
- Capecitabine therapy risk assessment
- Personalized oncology treatment planning
- Severe toxicity risk prediction
- Chemotherapy dose optimization
About Yourgene Health
Yourgene Health (formerly Premaitha Health) is a leading molecular diagnostics company specializing in reproductive health, precision medicine, and genetic testing solutions. The Elucigene range of products represents high-quality CE IVD certified diagnostic tests designed for clinical laboratory use.